Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels

Fig. 2

Systolic blood pressure during different treatment conditions in patients with a PAC above the median, and a PAC below the median. SBP is higher in the high PAC group in all treatment conditions, but the difference tends to decrease when treatment was intensified. Error bars represent standard error of the mean. SBP: systolic blood pressure; PAC: plasma aldosterone concentration; ARB: angiotensin receptor blocker (losartan 100 mg/day); LS: dietary sodium restriction; HCT: hydrochlorothiazide (25 mg/day)

Back to article page